Brainify.AI

Brainify.AI is an artificial intelligence company operating in the New York City AI scene [1]. Founded in 2021, the company operates as an AI biomarker platform focused on the development of novel treatments for depression [2]. According to its profile, Brainify.AI aims to increase the likelihood of new treatment approval and increase drug efficacy [2]. The company maintains partnerships with J&J Labs and Merck DSS [2]. Brainify.AI has received backing from the Merck GHI Fund, Northpond, and Kodori VC [2]. The company operates within the mental health care industry [3] and employs approximately 12 people [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.